Schizophrenia Disorder: Clinical Trials

29 trials for Schizophrenia Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 not yet recruiting, 8 recruiting, 7 completed, 2 enrolling by invitation. 18 Not applicable, 2 Phase 3, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable18Not yet recruiting 7, Recruiting 6, Completed 4, Enrolling by invitation 1
Phase 32Not yet recruiting 1, Recruiting 1
Phase 11Not yet recruiting 1
Phase 21Not yet recruiting 1

Follow Schizophrenia Disorder: new trials by email Literature Review of Schizophrenia Disorder trials Research Report on Schizophrenia Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Semaglutide Versus Placebo on Cardiometabolic Profile in Patients With Schizophrenia With Metabolic Syndrome
Semaglutide + TAU, Placebo + TAU - Schizophrenia Disorder, Metabolic Syndrome
Phase 3Not yet recruitingAll India Institute of Medical Sciences, Bhubaneswar6002026-12-012026-08-18
DecNef for Auditory Verbal Hallucinations (AVH) in Schizophrenia
Decoded Neurofeedback - Schizophrenia Disorder, Schizoaffecitve Disorder
Not applicableNot yet recruitingColumbia University512026-12-012026-10-14
A Prospective, Observational, Single-Arm, Multicenter Real-World Study Evaluating the Treatment Pattern, Safety and Effectiveness of Xanomeline and Trospium Chloride Capsules (KarXT) in the Treatment of Chinese Adult Participants With Schizophrenia
Xanomeline and trospium chloride (KarXT) - Schizophrenia Disorder
Not yet recruitingZai Lab (Shanghai) Co., Ltd.2502026-09-202026-09-03
Comparison of Accelerated Intermittent Theta Burst Stimulation vs High Frequency Transcranial Magnetic Stimulation (Hf-rTMS) on Cognitivesymptoms in Treatment-resistant Schizophrenia
Accelerated iTBS, High-Frequency rTMS, Sham rTMS - Psychosis, Schizophrenia Disorder
Not applicableNot yet recruitingAll India Institute of Medical Sciences, Bhubaneswar902026-09-152026-08-10
Medication Adherence in Severe Mental Illness: a Promotion Program
Telehealth Psychoeducational Adherence Program - Treatment Adherence and Compliance, Severe Mental Disorders
Not applicableNot yet recruitingInstituto de Investigación Sanitaria de la Fundación Jiménez Díaz16402026-09-012026-03-03
Reducing Mental Health Stigmatization Among Healthcare Workers and Students Using a Virtual Reality Protocol: The VIRTUS Protocol
VIRTUS, VR Control - Schizophrenia Disorder
Not applicableRecruitingCentre Hospitalier Henri Laborit1282026-08-172026-10-22
A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398
SIPI6398 Tablets - Schizophrenia Disorder
Phase 1 / Phase 2Not yet recruitingShanghai Zhongze Therapeutics Co., Ltd.92026-08-012026-06-04
Cognitive Strategies in Early Psychosis 2
Modafinil, D-serine solution, Placebo - Psychosis, Schizophrenia Disorder
Phase 3RecruitingUniversity of Minnesota242026-07-172026-07-23
Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression
neurostimulator - Autism Spectrum Disorder, Schizophrenia Disorder
Not applicableNot yet recruitingUniversity Hospital, Rouen62026-07-132026-06-08
MicroRNAs as Biomarkers in First Episode Schizophrenia
Plasma NDE miRNA Sequencing, Whole Genome Sequencing - Schizophrenia Disorder, Schizophreniform Disorder
Not applicableRecruitingNorthwell Health1602026-07-012026-07-14
dACC-Targeted Temporal Interference for Negative and Cognitive Symptoms in Schizophrenia
Temporal Interference Stimulation, Sham Temporal Interference Stimulation - Schizophrenia Disorder
Not applicableRecruitingShanghai Pudong New Area Mental Health Center, School of Medicine, Tongji University742026-06-302026-08-21
TIS for Improving Cognitive Impairment in Schizophrenia
temporal interference stimulation, Sham stimulation - Schizophrenia Disorder, Cognitive Impairments
Not applicableRecruitingCentral South University502026-06-242026-07-17
A Virtual Reality Mindfulness Application for Aggression in Schizophrenia
Mindfulness-Based Virtual Reality Intervention - Schizophrenia Disorder, Schizoaffecitve Disorder
Not applicableRecruitingManhattan Psychiatric Center582026-06-052026-06-10
Mechanisms of Sulforaphane Supplementation in Alleviating Negative Symptoms and Cognitive Impairment in Schizophrenia
Placebo, Sulforaphane - Schizophrenia Disorder
Not applicableNot yet recruitingSecond Xiangya Hospital of Central South University602026-06-022026-06-18
Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization
Financial incentives for adherence to long-acting injectable medication, Standard of care with monthly surveys - Schizophrenia Disorder, Schizoaffective Disorder
Not applicableEnrolling by invitationStanford University10002026-03-092026-10-23
Improving Health Literacy in Patients With Schizophrenia Spectrum Disorder
Educational sessions - Schizophrenia Disorder, Schizoaffective Disorder
Not applicableNot yet recruitingLouisiana State University Health Sciences Center in New Orleans342026-03-012026-03-23
Inter-Brain Synchrony in Schizophrenia
Fast Friends, Small Talk - Schizophrenia Disorder
Not applicableRecruitingUniversity of California, Los Angeles1002025-11-112026-08-11
AI-assisted Masticatory Muscle Training in Patients With Schizophrenia
AI-assisted Mastisting Training App - Schizophrenia Disorder
Not applicableNot yet recruitingKaohsiung Medical University Chung-Ho Memorial Hospital1002025-09-112025-09-04
Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With Schizophrenia
Schizophrenia Disorder
CompletedDr. Lutfi Kirdar Kartal Training and Research Hospital352025-08-192026-08-19
Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia Patients
Survey - Bipolar Disorder (BD), Schizophrenia Disorder
CompletedDr. Lutfi Kirdar Kartal Training and Research Hospital622025-06-232025-08-24

Showing 20 of 29. Sign in to see all of them.

Narrower conditions

Schizophrenia (29)  ·  Bipolar Disorder (5)  ·  Psychotic Disorders (5)  ·  Mental Disorders (3)  ·  Aggression (1)  ·  Alzheimer Disease (1)  ·  Anxiety Disorders (1)  ·  Autism Spectrum Disorder (1)  ·  Cognition Disorders (1)  ·  Cognitive Dysfunction (1)  ·  Depressive Disorder, Major (1)  ·  Emotional Regulation (1)  ·  Generalized Anxiety Disorder (1)  ·  Hallucinations (1)  ·  Insulin Resistance (1)

Broader conditions

Schizophrenia Spectrum and Other Psychotic Disorders (29)  ·  Mental Disorders (26)  ·  Behavior (5)  ·  Bipolar and Related Disorders (5)  ·  Mood Disorders (5)  ·  Neurocognitive Disorders (3)  ·  Health Behavior (2)  ·  Nervous System Diseases (2)  ·  Social Behavior (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Behavioral Symptoms (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Chemically-Induced Disorders (1)  ·  Child Development Disorders, Pervasive (1)

Interventions

3-carboxamido-4-hydroxynaltrexone (1)  ·  Cognitive Behavioral Therapy (1)  ·  Implantable Neurostimulators (1)  ·  Modafinil (1)  ·  Olanzapine (1)  ·  Risperidone (1)  ·  Standard of Care (1)  ·  Surveys and Questionnaires (1)  ·  Whole Genome Sequencing (1)  ·  lybalvi (1)  ·  semaglutide (1)  ·  sulforaphane (1)  ·  trospium chloride (1)  ·  xanomeline (1)

Sponsors

All India Institute of Medical Sciences, Bhubaneswar (2)  ·  Dr. Lutfi Kirdar Kartal Training and Research Hospital (2)  ·  Alkermes, Inc. (1)  ·  Central South University (1)  ·  Centre Hospitalier Henri Laborit (1)  ·  Columbia University (1)  ·  Dokuz Eylul University (1)  ·  Elazığ Mental Health and Diseases Hospital (1)  ·  Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1)  ·  Halic University (1)  ·  Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  Louisiana State University Health Sciences Center in New Orleans (1)  ·  Manhattan Psychiatric Center (1)  ·  Northwell Health (1)

Countries

United States (8)  ·  Turkey (Türkiye) (6)  ·  China (4)  ·  France (2)  ·  Denmark (1)  ·  India (1)  ·  Israel (1)  ·  Spain (1)

Top investigators

Antoine Douaihy, MD (1)  ·  Anzalee Khan, PhD (1)  ·  Caroline Demro, Ph.D. (1)  ·  Eric Reavis, Phd (1)  ·  Guillermo Horga, MD, PhD (1)  ·  Hsieh Hsiu Fen, PhD (1)  ·  Jean-Pierre Lindenmayer, MD (1)  ·  Jonathan K Wynn, PhD (1)  ·  Joshua Kantrowitz, MD (1)  ·  Juan Gallego, MD (1)  ·  Shahak Yariv, MD (1)  ·  Sophia Vinogradov, MD (1)

Results publications

PMID 23714262, PMID 28078204, PMID 31077729, PMID 31150942, PMID 33761085, PMID 34639510, PMID 42556844, PMID 42745898

NIH funding

P50MH119569 (1), R21MH139044 (1), R61MH133785 (1), R61MH143195 (1)